Aspirin could prevent breast cancer in women with type 2 diabetes

Jack Woodfield
Fri, 09 Jun 2017
Aspirin could prevent breast cancer in women with type 2 diabetes
Low doses of aspirin could significantly lower the chances of women with type 2 diabetes developing breast cancer, according to new research.

However, aspirin, which can be purchased over the counter at a chemist and is normally taken by people to help treat pain, fever, and inflammation, can increase the risk of bleeding. It is therefore recommended to start taking aspirin regularly without your doctor's agreement, and people with diabetes should consult their doctor before taking aspirin for any prevention purposes.

In the study 149,000 females with type 2 diabetes were monitored across 14 years. Researchers discovered those who took a low dose (75-165 mg) of aspirin on a daily basis reduced their chances of developing breast cancer by 18 per cent.

When the researchers reviewed women who had been on high doses of aspirin (more than 88,900 mg daily), there was a 47 per cent reduction in breast cancer when compared to those who had not taken any doses of the drug on a regular basis.

Low doses of the drug are often prescribed to help cardiovascular disease in people with diabetes in other countries. In the UK, taking aspirin to prevent heart disease is not generally recommended because there is an increased risk of bleeding which could raise the risk of haemorrhagic stroke.

The researchers said: "In conclusion, our findings suggest that the cumulative aspirin dosage of more than 88,900 mg daily was associated with a reduced risk of breast cancer in patients with diabetes after adjustments for potential confounders, namely age and underlying comorbidities."

Dr Susan Kornstein, MD, editor-in-chief of Journal of Women's Health said: "Women with type 2 diabetes have an increased risk of breast cancer, and these results suggest that the same low-dose aspirin that many of these women take to prevent cardiovascular disease may also help reduce their risk of breast cancer."

The researchers added that additional studies are required to validate their findings, which have been published in the Journal of Women's Health.
Leave a Comment
Login via Facebook
or
Have your say in the Diabetes Forum
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.